See All Slides - tctmd.com

Slides

Presentation TCT 2012

DESyneBD (Elixir Medical) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

Yes: The Quantitative Threshold Should Be Lowered!

Presenter: Maurice Sarano

October 23, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

CABG Today Is Over-Utilized!

Presenter: William Fearon

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints

Presenter: John Ormiston

October 23, 2012

Presentation TCT 2012

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Presenter: Paul Gurbel

October 23, 2012

Presentation TCT 2012

Point-of-Care Platelet and Genetic Testing

Presenter: Jessica Mega

October 23, 2012

Advertisement

Slides

DESyneBD (Elixir Medical) Program Update

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Yes: The Quantitative Threshold Should Be Lowered!

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Autologous Cardiac Stem Cells in VAD Patients

CABG Today Is Over-Utilized!

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints

TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study

Point-of-Care Platelet and Genetic Testing

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content